Press release attachment.
Company Name : Minapharm Pharmaceuticals
ISIN Code: EGS380G1C011
Currency: EGP
F/S Consolidated Period : From 01/01/2026 To 30/06/2026
Net Profit: 108,495,994
F/S Consolidated Period : From 01/01/2025 To 30/06/2025
Net Comparative Loss : 211,636,746
Audit Status : Reviewed
Comment :Take into consideration the minority rights
Source: Minapharm Pharmaceuticals